Abstract:Iron deficiency is the most prevalent human micronutrient deficiency, disrupting the physiological development of millions of infants and children. Oral iron supplementation is used to address iron-deficiency anemia and reduce associated stunting but can promote infection risk since restriction of iron availability serves as an innate immune mechanism against invading pathogens. Raised iron availability is associated with an increase in enteric pathogens, especially Enterobacteriaceae species, accompanied by reductions in beneficial bacteria such as Bifidobacteria and lactobacilli and may skew the pattern of gut microbiota development. Since the gut microbiota is the primary driver of immune development, deviations from normal patterns of bacterial succession in early life can have long-term implications for immune functionality. There is a paucity of knowledge regarding how both iron deficiency and luminal iron availability affect gut microbiota development, or the subsequent impact on immunity, which are likely to be contributors to the increased risk of infection. Piglets are naturally iron deficient. This is largely due to their low iron endowments at birth (primarily due to large litter sizes), and their rapid growth combined with the low iron levels in sow milk. Thus, piglets consistently become iron deficient within days of birth which rapidly progresses to anemia in the absence of iron supplementation. Moreover, like humans, pigs are omnivorous and share many characteristics of human gut physiology, microbiota and immunity. In addition, their precocial nature permits early maternal separation, individual housing, and tight control of nutritional intake. Here, we highlight the advantages of piglets as valuable and highly relevant models for human infants in promoting understanding of how early iron status impacts physiological development. We also indicate how piglets offer potential to unravel the complexities of microbiota-immune responses during iron deficiency and in response to iron supplementation, and the link between these and increased risk of infectious disease.

Pig models on intestinal development and therapeutics

Effect of Exogenous Fecal Microbiota Intervention on Intestinal Barrier Function in Recipient Pigs

Progress on Swine Biomedical Model

Roles of amino acids in preventing and treating intestinal diseases: recent studies with pig models

Critical review evaluating the pig as a model for human nutritional physiology

Advances in Pig Models of Human Diseases

Porcine Intestinal Organoids: Overview of the State of the Art

Microbiomes in the Intestine of Developing Pigs: Implications for Nutrition and Health.

The pig as a model for immunology research

Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges

Effects of iron deficiency and iron supplementation at the host-microbiota interface: Could a piglet model unravel complexities of the underlying mechanisms?

Inter-species transplantation of gut microbiota from human to pigs

Comparative Evaluation of the Ileum Microbiota Composition in Piglets at Different Growth Stages

The Roles of Polyamines in Intestinal Development and Function in Piglets

Importance of the pig as a human biomedical model

Nutritional intervention for the intestinal development and health of weaned pigs

Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke?

Probiotics in Piglet: from Gut Health to Pathogen Defense Mechanisms

Recent advances in the use of Sus scrofa (pig) as a model system for proteomic studies

Advances and applications of genetically modified pig models in biomedical and agricultural field.